Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to examine the mood stabilizing and antipsychotic properties of quetiapine in the treatment of depression by comparing subjects who were randomly assigned to either quetiapine monotherapy, quetiapine and citalopram; or haloperidol and citalopram. We hypothesize that quetiapine monotherapy would have similar effects to the combination of a first generation antipsychotic plus an antidepressant for the treatment of a major depressive episode with psychosis.


Clinical Trial Description

Thus, current practice for treating psychotic depression is to combine an antidepressant with an antipsychotic. However, there are limitations to this approach. The rate of response is still lower than in other forms of major depression (Janicak et al., 2001). The rate of noncompliance is higher in this group; and the incidence of adverse effects related to the antipsychotic is increased (Janicak et al., 2001). As a result, studies have examined alternative treatments. The present study proposes to examine quetiapine's antipsychotic and mood stabilizing properties for the treatment of a major depressive disorder with psychotic features Subjects will be randomized to either quetipine monotherapy, quetiapine and citalopram; or haloperidol and citalopram. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00174603
Study type Interventional
Source Rush University Medical Center
Contact
Status Terminated
Phase Phase 3
Start date August 2005
Completion date January 2007

See also
  Status Clinical Trial Phase
Terminated NCT00174590 - Treatment of Major Depressive Disorder With Psychotic Features. Phase 3
Completed NCT01259427 - Reducing Internalized Stigma in People With Serious Mental Illness Phase 2
Terminated NCT01624831 - Social Cognition in Longstanding Psychosis
Recruiting NCT05877716 - EPI-MINN: Targeting Cognition and Motivation - National N/A
Recruiting NCT04497857 - Academic-Community EPINET (AC-EPINET) N/A
Completed NCT01196286 - Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis N/A
Recruiting NCT04004416 - Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis Phase 4
Completed NCT01570972 - Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis N/A